Aktis Oncology, Inc. Common stock (AKTS) — Capital Reinvestment Ratio
Aktis Oncology, Inc. Common stock (AKTS) has a Capital Reinvestment Ratio of 0.19x as of December 2024, meaning it reinvests 0% of its operating cash flow ($14.76 Million) in capital expenditures ($2.86 Million). See net asset quality index of Aktis Oncology, Inc. Common stock to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aktis Oncology, Inc. Common stock Capital Reinvestment Ratio (2024–2024)
This chart tracks Aktis Oncology, Inc. Common stock's Capital Reinvestment Ratio across 1 annual periods. Check Aktis Oncology, Inc. Common stock investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Aktis Oncology, Inc. Common stock (2024–2024)
Year-by-year Capital Reinvestment Ratio for Aktis Oncology, Inc. Common stock from 2024 to 2024. For live market cap and broader valuation context, see Aktis Oncology, Inc. Common stock market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | $14.76 Million | $2.86 Million | — |